Shane Colborne

890 total citations
10 papers, 342 citations indexed

About

Shane Colborne is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shane Colborne has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shane Colborne's work include Protein Degradation and Inhibitors (3 papers), Cancer Mechanisms and Therapy (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Shane Colborne is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Cancer Mechanisms and Therapy (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Shane Colborne collaborates with scholars based in Canada, United States and Australia. Shane Colborne's co-authors include Gregg B. Morin, Christopher S. Hughes, Torsten O. Nielsen, Sandra E. Spencer Miko, Jessica D. Lang, Krystal A. Orlando, Marcel B. Bally, Gian Luca Negri, Anthony N. Karnezis and Nancy Dos Santos and has published in prestigious journals such as Nature Communications, Cancer Research and Cell Death and Differentiation.

In The Last Decade

Shane Colborne

10 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shane Colborne Canada 8 252 83 64 60 51 10 342
Laura Devis Spain 8 229 0.9× 21 0.3× 76 1.2× 142 2.4× 62 1.2× 11 408
Tao Xiang China 6 351 1.4× 29 0.3× 62 1.0× 31 0.5× 25 0.5× 11 436
Nada Albarakati United Kingdom 10 346 1.4× 40 0.5× 161 2.5× 88 1.5× 12 0.2× 15 421
Mykola Chekan Poland 15 290 1.2× 21 0.3× 67 1.0× 113 1.9× 12 0.2× 20 484
Alex Xiu‐Cheng Fan Switzerland 11 276 1.1× 39 0.5× 73 1.1× 159 2.6× 19 0.4× 16 425
Tayyebeh M. Nazeran Canada 10 149 0.6× 54 0.7× 45 0.7× 84 1.4× 16 0.3× 13 433
Donna Hewitt Canada 5 194 0.8× 46 0.6× 94 1.5× 63 1.1× 9 0.2× 12 351
Sibylle Gündisch Germany 11 261 1.0× 14 0.2× 71 1.1× 83 1.4× 15 0.3× 12 387
Isabelle Miran France 7 146 0.6× 40 0.5× 129 2.0× 34 0.6× 12 0.2× 10 334
Jitka Hausnerová Czechia 10 142 0.6× 14 0.2× 70 1.1× 93 1.6× 24 0.5× 37 297

Countries citing papers authored by Shane Colborne

Since Specialization
Citations

This map shows the geographic impact of Shane Colborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Colborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Colborne more than expected).

Fields of papers citing papers by Shane Colborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Colborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Colborne. The network helps show where Shane Colborne may publish in the future.

Co-authorship network of co-authors of Shane Colborne

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Colborne. A scholar is included among the top collaborators of Shane Colborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Colborne. Shane Colborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Asleh, Karama, Gian Luca Negri, Sandra E. Spencer Miko, et al.. (2022). Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. Nature Communications. 13(1). 896–896. 82 indexed citations
2.
Xu, Jing, Kevin Yang, Nancy E. Go, et al.. (2022). Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations. Autophagy. 18(11). 2547–2560. 51 indexed citations
3.
Shrestha, Raunak, Marta Llauradó Fernández, Amy Dawson, et al.. (2021). Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability. Cancer Research. 81(7). 1681–1694. 26 indexed citations
4.
Lefort, Sylvain, Amal M. El-Naggar, Susanna Tan, et al.. (2021). De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer. Cell Death and Differentiation. 29(1). 54–64. 4 indexed citations
5.
Kuechler, Erich R., et al.. (2021). Protein feature analysis of heat shock induced ubiquitination sites reveals preferential modification site localization. Journal of Proteomics. 239. 104182–104182. 4 indexed citations
6.
Cochrane, Dawn R., Jennifer Pors, Gian Luca Negri, et al.. (2020). Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers. Human Pathology. 108. 1–11. 7 indexed citations
7.
Colborne, Shane, et al.. (2019). The FUS-DDIT3 Interactome in Myxoid Liposarcoma. Neoplasia. 21(8). 740–751. 28 indexed citations
8.
Wang, Yemin, Shane Colborne, Nancy Dos Santos, et al.. (2018). Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type. Molecular Cancer Therapeutics. 17(12). 2767–2779. 52 indexed citations
9.
Kovalchik, Kevin A., Shane Colborne, Sandra E. Spencer Miko, et al.. (2018). RawTools: Rapid and Dynamic Interrogation of Orbitrap Data Files for Mass Spectrometer System Management. Journal of Proteome Research. 18(2). 700–708. 17 indexed citations
10.
Wang, Yemin, Anthony N. Karnezis, Shane Colborne, et al.. (2017). The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type. The Journal of Pathology. 242(3). 371–383. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026